ストックスクリーナーアプリを入手
4.60
8.73%
-0.44
アフターアワーズ：
4.64
0.04
+0.87%
Lenz Therapeutics Inc (LENZ) 最新ニュース
Lenz stock drops as Bank of America downgrades (LENZ:NASDAQ) - Seeking Alpha
BofA downgrades Lenz Therapeutics stock rating on slow launch By Investing.com - Investing.com Australia
BofA downgrades Lenz Therapeutics stock rating on slow launch - Investing.com
Why is LENZ Therapeutics stock rallying today? - Investing.com
Why is LENZ Therapeutics stock rallying today? By Investing.com - Investing.com Canada
LENZ Therapeutics earnings beat by $0.05, revenue topped estimates - Investing.com Canada
LENZ Therapeutics, Inc. Stock 12‑Month Price Target Cut to $29.86, Implies 473% Upside - TradingView
LENZ Therapeutics Inc (LENZ) (Q2 2026) Earnings Call Highlights: VIZZ Launch Momentum ... By GuruFocus - Investing.com Canada
Lenz Therapeutics Posts Q2 Revenue Fueled by VIZZ Sales and License Agreements - VisionMonday.com
LENZ Therapeutics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
LENZ Therapeutics Q2 Earnings Call Highlights - TradingView
LENZ Therapeutics (NASDAQ:LENZ) Issues Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
LENZ Therapeutics Q2 Results: Sales surge 131% vs estimates - scanx.trade
LENZ Therapeutics, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
LENZ: July prescriptions surged 45%+ after telehealth and TV launches, with strong patient persistence - TradingView
LENZ Therapeutics, Inc. (LENZ) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Earnings call transcript: LENZ Therapeutics tops Q2 2026 forecasts as sales jump - Investing.com
Transcript : LENZ Therapeutics, Inc., Q2 2026 Earnings Call, Aug 11, 2026 - marketscreener.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - benzinga.com
LENZ Therapeutics (LENZ) grows VIZZ sales but posts $31.9M Q2 loss - Stock Titan
LENZ THERAPEUTICS ($LENZ) Releases Q2 2026 Earnings, Stock Rises - Quiver Quantitative
LENZ Therapeutics Q2 revenue rises on VIZZ sales - TradingView
LENZ Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - ir.lenz-tx.com
Over 60% of LENZ’s VIZZ ePharmacy Patients Bought Multiple Packs - Stock Titan
LENZ Therapeutics Inc (NASDAQ: LENZ) Share Price, LENZ Stock News, LENZ Share Price & Updates - Kalkine
LENZ Therapeutics Inc (LENZ) Q2 2026 Earnings Report Preview: Wh - GuruFocus
LENZ Therapeutics, Inc. (LENZ) Stock Analysis: A Biotech With A Potential 513% Upside - DirectorsTalk Interviews
LENZ Therapeutics Inc (LENZ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
LENZ Therapeutics to Report Second Quarter 2026 Financial Results and Recent Corporate Highlights on August 11, 2026 - marketscreener.com
LENZ|LENZ Therapeutics Inc|Price:5.695|Chg%:+0.215 - TradingKey
LENZ Therapeutics Inc (LENZ) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
LENZ Therapeutics Inc (LENZ) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
LENZ Therapeutics Inc (LENZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LENZ Therapeutics, Inc. Revenue Breakdown – NASDAQ:LENZ - TradingView
LENZ Therapeutics Inc (LENZ) Cash Flow - TradingKey
TradingKey - TradingKey
LENZ Therapeutics Inc (LENZ) Institutional Confidence - TradingKey
LENZ Therapeutics Inc expected to post a loss of $1.07 a shareEarnings Preview - TradingView
LENZ Therapeutics Inc (LENZ) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
LENZ|LENZ Therapeutics Inc|Price:5.750|Chg%:+0.051 - TradingKey
LENZ Therapeutics (LENZ) Q1 2026 earnings summary - Quartr
LENZ Therapeutics (LENZ) 2024 Cantor Fitzgerald Global Healthcare Conference Summary - Quartr
LENZ Therapeutics Inc (LENZ) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
LENZ Therapeutics (LENZ) TD Cowen 46th Annual Health Care Conference Summary - Quartr
Earnings preview: LENZ Therapeutics, Inc. (LENZ) Q2 earnings expected to decline - MSN
Earnings Preview: LENZ Therapeutics, Inc. (LENZ) Q2 Earnings Expected to Decline - Yahoo Finance
LENZ Therapeutics (LENZ) Morgan Stanley 23rd Annual Global Healthcare Conference summary - Quartr
LENZ Therapeutics (LENZ) Projected to Post Earnings on Wednesday - MarketBeat
LENZ Therapeutics (LENZ) Leerink Global Healthcare Conference 2026 Summary - Quartr
LENZ Therapeutics (LENZ) Proxy filing Summary - Quartr
We're Hopeful That LENZ Therapeutics (NASDAQ:LENZ) Will Use Its Cash Wisely - Sahm
LENZ Therapeutics (LENZ) Stock Fair Value Moves Lower As Analysts Reset Growth Assumptions - Yahoo Finance
Analysts Are Neutral on These Healthcare Stocks: LENZ Therapeutics (LENZ), Agilent (A) - The Globe and Mail
Piper Sandler Maintains LENZ Therapeutics(LENZ.US) With Hold Rating, Maintains Target Price $12 - Moomoo
H.C. Wainwright Maintains LENZ Therapeutics(LENZ.US) With Buy Rating, Maintains Target Price $38 - Moomoo
LENZ Therapeutics Launches VIZZ Telehealth Prescribing Option for the Treatment of Presbyopia - VisionMonday.com
H.C. Wainwright reiterates Buy on LENZ Therapeutics stock on telehealth launch - Investing.com Nigeria
LENZ Reiterates by HC Wainwright & Co. -- Price Target Maintained at $38 - GuruFocus
LENZ Therapeutics, Inc. Launches New Telehealth Prescribing Option for VIZZ for the Treatment of Presbyopia - marketscreener.com
William Blair Maintains LENZ Therapeutics(LENZ.US) With Buy Rating - Moomoo
LENZ Therapeutics Launches Telehealth Access for VIZZ Alongside National TV Campaign - Moomoo
0.03%
0.33%
大文字化:
|
ボリューム (24 時間):